Synergistic Effects of the GATA-4-mediated MiR-144/451 Cluster in Protection Against Simulated Ischemia/reperfusion-induced Cardiomyocyte Death
Overview
Authors
Affiliations
Among the identified microRNAs (miRs) thus far, ~50% of mammalian miRs are clustered in the genome and transcribed as polycistronic primary transcripts. However, whether clustered miRs mediate non-redundant and cooperative functions remains poorly understood. In this study, we first identified activation of the promoter of miR-144/451 by GATA-4, a critical transcription factor in the heart. Next, we observed that ectopic expression of miR-144 and -451 individually augmented cardiomyocyte survival, which was further improved by overexpression of miR-144/451, compared to control cells in response to simulated ischemia/reperfusion. In contrast, knockdown of endogenous miR-144 and -451 revealed opposite effects. Using luciferase reporter assay and western blot analysis, we also validated that both miR-144 and miR-451 target CUG triplet repeat-binding protein 2 (CUGBP2), a ubiquitously expressed RNA-binding protein, known to interact with COX-2 3'UTR and inhibit its translation. Accordingly, protein levels of CUGBP2 were greatly reduced and COX-2 activity was markedly increased in miR-144-, miR-451-, and miR-144/451-overexpressing cardiomyocytes, compared to GFP cells. Furthermore, inhibition of COX-2 activity by either NS-398 or DUP-697 partially offset protective effects of the miR-144/451 cluster. Together, these data indicate that both partners of the miR-144/451 cluster confer protection against simulated I/R-induced cardiomyocyte death via targeting CUGBP2-COX-2 pathway, at least in part. Thus, both miR-144 and miR-451 may represent new therapeutic agents for the treatment of ischemic heart disease.
Wang F, Mu G, Yu Z, Qin Z, Zhao X, Shi Z Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996848 PMC: 11854642. DOI: 10.3390/cimb47020127.
Gheitasi I, Akbari G, Savari F Mol Cell Biochem. 2024; 480(2):855-868.
PMID: 39001984 DOI: 10.1007/s11010-024-05052-7.
Amaro-Prellezo E, Gomez-Ferrer M, Hakobyan L, Ontoria-Oviedo I, Peiro-Molina E, Tarazona S Inflamm Regen. 2024; 44(1):25.
PMID: 38807194 PMC: 11134765. DOI: 10.1186/s41232-024-00340-7.
Lage R, Cebro-Marquez M, Vilar-Sanchez M, Gonzalez-Melchor L, Garcia-Seara J, Martinez-Sande J Cells. 2023; 12(4).
PMID: 36831306 PMC: 9953933. DOI: 10.3390/cells12040638.
Breulmann F, Hatt L, Schmitz B, Wehrle E, Richards R, Della Bella E Clin Transl Med. 2023; 13(1):e1161.
PMID: 36629031 PMC: 9832434. DOI: 10.1002/ctm2.1161.